Literature DB >> 24109230

Varicella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures.

Jenna Christensen1, Megan Steain, Barry Slobedman, Allison Abendroth.   

Abstract

Neurons of the sensory ganglia are the major site of varicella-zoster virus (VZV) latency and may undergo productive infection during reactivation. Although the VZV glycoprotein E/glycoprotein I (gE/gI) complex is known to be critical for neurovirulence, few studies have assessed the roles of these proteins during infection of dorsal root ganglia (DRG) due to the high human specificity of the virus. Here, we show that the VZV glycoprotein I gene is an important neurotropic gene responsible for mediating the spread of virus in neuronal cultures and explanted DRG. Inoculation of differentiated SH-SY5Y neuronal cell cultures with a VZV gI gene deletion strain (VZV rOkaΔgI) showed a large reduction in the percentage of cells infected and significantly smaller plaque sizes in a comparison with cultures infected with the parental strain (VZV rOka). In contrast, VZV rOkaΔgI was not significantly attenuated in fibroblast cultures, demonstrating a cell type-specific role for VZV gI. Analysis of rOkaΔgI protein localization by immunofluorescent staining revealed aberrant localization of viral glycoprotein and capsid proteins, with little or no staining present in the axons of differentiated SH-SY5Y cells infected with rOkaΔgI, yet axonal vesicle trafficking was not impaired. Further studies utilizing explanted human DRG indicated that VZV gI is required for the spread of virus within DRG. These data demonstrate a role for VZV gI in the cell-to-cell spread of virus during productive replication in neuronal cells and a role in facilitating the access of virion components to axons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24109230      PMCID: PMC3838295          DOI: 10.1128/JVI.02293-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking.

Authors:  S Mallory; M Sommer; A M Arvin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Herpes simplex virus gE/gI and US9 proteins promote transport of both capsids and virion glycoproteins in neuronal axons.

Authors:  Aleksandra Snyder; Katarina Polcicova; David C Johnson
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

3.  Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus.

Authors:  K S Dingwell; L C Doering; D C Johnson
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Productive varicella-zoster virus infection of cultured intact human ganglia.

Authors:  Kavitha Gowrishankar; Barry Slobedman; Anthony L Cunningham; Monica Miranda-Saksena; Ross A Boadle; Allison Abendroth
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

5.  Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.

Authors:  Leigh Zerboni; Barbara Berarducci; Jaya Rajamani; Carol D Jones; James L Zehnder; Ann Arvin
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

6.  Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9.

Authors:  Helen M McGraw; Sita Awasthi; Jason A Wojcechowskyj; Harvey M Friedman
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

Review 7.  The neurotropic herpes viruses: herpes simplex and varicella-zoster.

Authors:  Israel Steiner; Peter G E Kennedy; Andrew R Pachner
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

8.  Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.

Authors:  Leigh Zerboni; Mike Reichelt; Carol D Jones; James L Zehnder; Hideki Ito; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

Review 9.  Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Authors:  Niklaus H Mueller; Donald H Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

10.  Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia.

Authors:  Mike Reichelt; Leigh Zerboni; Ann M Arvin
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

View more
  3 in total

1.  Differentiated Human SH-SY5Y Cells Provide a Reductionist Model of Herpes Simplex Virus 1 Neurotropism.

Authors:  Mackenzie M Shipley; Colleen A Mangold; Chad V Kuny; Moriah L Szpara
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

2.  The Structures and Functions of VZV Glycoproteins.

Authors:  Stefan L Oliver
Journal:  Curr Top Microbiol Immunol       Date:  2021-11-04       Impact factor: 4.737

3.  Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.

Authors:  Ieva Bagdonaite; Rickard Nordén; Hiren J Joshi; Sarah L King; Sergey Y Vakhrushev; Sigvard Olofsson; Hans H Wandall
Journal:  J Biol Chem       Date:  2016-04-15       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.